PATENT CLAIM ANALYSIS

Application Number: 15979881
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "009100"]

Abstract:
Modified FGF-21 polypeptides and uses thereof are provided, for example, for the treatment of diseases associated with fibrosis. Modified FGF-21 polypeptides are disclosed that contain an internal deletion and optionally replacement peptide, optionally modified with at least one non-naturally-encoded amino acid, and/or optionally fused to a fusion partner.

Claim (Index 96):
A modified FGF-21 polypeptide comprising an internal deletion, wherein said modified FGF-21 polypeptide comprises an amino acid sequence having at least 95% amino acid sequence identity to SEQ ID NO: 202.

Metadata:
- Claim Count in Document: 110.0
- Percentile: 93.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15460917', '14921796', '15215329', '15292700', '14680543']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7644348135114375
- 35 USC 102 Novelty (BERT): 0.6030693988505915
- Combined Prediction Score: 0.7482982720453529
- Mean Citation Score: 453.04554400000006
- Max Citation Score: 550.8938
- Similarity Product: 477.4957395163536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test